InsiderTrades

Form 4 for OLMA Olema Pharmaceuticals, Inc.

Accepted 2021-07-13 00:00:00 ET · period of report 2021-07-12 · accession 0001415889-21-003598 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-13 2021-07-12 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $2.06 +5,251 7,041 +293% +$10.8K
DM 2021-07-13 2021-07-12 OLMA Horn Kinney Chief BUSINESS Off S - Sale+OE $26.51 -5,251 3,182 -62% -$139.2K
D 2021-07-13 2021-07-12 OLMA Horn Kinney Chief BUSINESS Off M - OptEx $0.00 -5,251 183.8K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-12 M A 5,251 $2.06 7,041 D — —
2 Common Common Stock 2021-07-12 S D 1,392 $27.00 1,790 D — — (F3) The weighted average sale price for the transaction reported was $27.00, and the range of prices were between $26.80 and $27.16. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
3 Common Common Stock 2021-07-12 S D 3,859 $26.33 3,182 D — — (F2) The weighted average sale price for the transaction reported was $26.33, and the range of prices were between $25.74 and $26.72. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
4 Derivative Stock Option (Right to Buy) 2021-07-12 M D 5,251 $0.00 183,795 D $2.06 · — to 2030-06-09 5,251 Common Stock (F4) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.